APOE Gene Added to the Nutrition Genome Report
Recently, the FDA gave 23andme the approval to tell people their APOE gene variant that is associated with late-onset Alzheimer’s disease.
I have received requests from practitioners to add this gene to the Nutrition Genome Report, and inquiries from clients who are concerned due to their family history of Alzheimer’s disease and their APOE genotype. Today, I added the gene, along with a comprehensive understanding of APOE and strategies to lower your risk of Alzheimer’s and dementia.
Do APOE Variants Increase Your Risk of Alzheimer’s Disease?
The first thing you should know is that many individuals with the APOE-ε4 allele never develop the Alzheimer’s and many patients with Alzheimer’s disease do not have the APOE-ε4 allele. Knowing if you are APOE-ε4 appears to be useful as part of the entire genetic blueprint in determining dietary and exercise needs to prevent Alzheimer’s if it runs in your family.
While over 60% of people with Alzheimer’s disease harbor at least one APOE-ε4 allele, it has been recommended that the APOE-ε4 test is not to be used for the prediction of Alzheimer disease risk because there are many other epigenetic factors at play.
Postmenopausal women constitute more than 60% of the affected Alzheimer population, highlighting a potential estrogen connection. It is recommended that you look at ACSL1, TCF72, PEMT, CAT, SOD2, GPX, SHBG (for women), MTHFR, FUT2 and GAD1 genes in the Nutrition Genome Report for a more comprehensive perspective on the pathways associated with Alzheimer’s disease and strategies to prevent it.
What is the APOE Gene?
APOE is a cholesterol transporter and functions as a key regulator to coordinate the mobilization of cholesterol between cells and remove toxins. These functions are particularly critical for the nervous system where the APOE transport of cholesterol is critical for maintenance of brain neurons.
Two homozygous APOE genes determine your genotype (e2, e3, and e4). The e4 genotype is found today in 15% of individuals and is the one most correlated to late-onset Alzheimer’s disease. The risk of cognitive decline conferred by carrying the E4 allele is greater among people from northern Europe.
The e4 allele was common in our hunter-gatherer ancestors and is still highly prevalent in remaining foraging societies. The e3 allele (found in 78% of people) is the most common in humans, especially in regions with a long-established agricultural economy showing the mutation likely occurred during our change to an agricultural diet.
The Cost/Benefit of APOE4
Some of you read about the Tp53 gene in your Nutrition Genome Report. Variants in this gene increased the probability of conception in cold weather, showing an adaptation to the climate for procreation. The downside is that it increases the sensitivity to the UV rays of the sun for those of us who moved from a northern climate to a southern climate.
APOE-ε4 is a gene that confers an advantage in one period of life but later presents as a disadvantage. During the hunter-gatherer era, APOE-ε4 appeared beneficial in protecting against miscarriage, stillbirth, and diseases evoked by both viruses and bacteria. The trade-off, however, was decreased injury repair to the brain later in life that most likely didn’t occur during the hunter-gatherer era due to a shorter life span.
So it made more sense for our species to select APOE-ε4 because early life survival was a bigger threat. APOE-ε4 carriers have also been shown to exhibit cognitive benefits earlier in life and higher intestinal absorption of dietary vitamin D and calcium, promoting stronger bones.
I have the APOE-ε4 Genotype. What Should I Do?
#1 Lower Oxidative Stress: Compared to APOE-ε2 and APOE-ε3, APOE-ε4 was less effective in protecting cells from oxidative toxicity. Look at your GAD1 genes and use the strategies to balance glutamate and GABA. Both the GPX gene and PON1 gene were affected by APOE-ε4, making these genes targets to strengthen.
#2 Avoid high-risk activities for traumatic brain injuries: Increasing evidence has shown that APOE-ε4 genotype is associated with poorer outcomes following traumatic brain injury (TBI), likely due to the reduced ability to repair synapses and protect neurons from injury. TBI’s are associated with increased risk of Alzheimer’s disease.
#3 Increase your exercise and fast for 12-16 hours between dinner and breakfast: Both of these strategies have proven to be critical for positive APOE-ε4 function. Remember, this is a hunter-gatherer genotype, compounding the negative effects of a sedentary lifestyle and grain-based diet.
#4 Sleep 7-8 hours each night: Sleep is where repair and detoxification take place. Studies have found that disturbed sleep amplifies the adverse effects of APOE-ε4 and increases the risk of Alzheimer’s disease. Be aware that sleep aids that are anticholinergic drugs also increase the risk of cognitive decline. Melatonin, magnesium, valerian and other natural methods are recommended.
#5 Consider Ashwagandha and Lithium: Amyloid plaques are the sticky buildup of proteins that accumulate outside nerve cells. The current theory is that the APOE-ε4 genotype shows a reduced clearance of beta amyloid. Researchers have demonstrated that when ashwagandha was added to β-amyloid treated samples, the toxic effects were neutralized and ashwagandha root extract was neuroprotective against β-amyloid induced neuropathogenesis.
Researchers have also found that continued lithium treatment was associated with a reduction in the rate of dementia and can actually be neuroprotective or even enhance the growth of neurons.
The APOE gene is associated with Alzheimer’s disease, but it cannot predict you getting it. Case studies have shown tremendous progress with diet, exercise and lifestyle changes for slowing and even reversing symptoms.
Like all of our genes, the epigenetic expression through our diet, exercise and lifestyle ultimately determine the function. For APOE-ε4, this means a more conscious regime of targeting key pathways if Alzheimer’s disease runs in your family.
Having this information along with the rest of your Nutrition Genome Report allows you to take control and modify the risk of Alzheimer’s disease. This has been validated with cardiovascular risk genes, and I believe future research will prove the epigenetic lifestyle changes with the genes associated with Alzheimer’s disease as well.
Find more strategies for Alzheimer’s disease by downloading the Nutrition Genome Report.